REG - One Health Group PLC - Full Year Trading Update

One HealthAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260427:nRSa8947Ba&default-theme=true

RNS Number : 8947B  One Health Group PLC  27 April 2026

 

One Health Group plc

("One Health", the "Company" or the "Group")

 

Full Year Trading Update

 

FY 26 revenue and underlying EBITDA ahead of market expectations

Strong growth across all KPIs

 

One Health Group plc (AIM: OHGR), the independent provider of NHS-funded
surgical procedures for patients referred from the NHS through 'Patient
Choice', provides the following trading update for the year ended 31 March
2026 ("FY 26"), showing continued growth, ahead of market expectations.(1)

 

Key Highlights

 

                                                  FY 26     FY 25     Growth

 Revenue                                          £32.0m    £28.4m    13%
 New NHS patient referrals                         18,931    17,020   11%
 Number of consultations                           50,774    42,238   20%
 Number of surgical procedures                     8,113     7,043    15%
 Number of consultants (excluding anaesthetists)  88        80        10%
 Number of Outreach Clinics                       40        37        8%
 Number of Surgical Operating Facilities          14        10        40%

 

Surgical Hub progress

·    As announced on 23 February
(https://www.londonstockexchange.com/news-article/OHGR/planning-sign-off-and-surgical-hub-construction/17473085)
, construction of the Company's first Surgical Hub in Scunthorpe,
Lincolnshire, has commenced

·    The project is on track to be delivered within the one-year
construction period and in line with the previous cost estimate of £8m to
£9m

·    Further locations in underserved areas with high NHS demand continue
to be explored for preliminary assessment of suitability for future surgical
hubs

 

Outlook

The Board is confident in the Company's strategy to drive continued organic
growth through increased patient referrals, a strong pipeline of new surgeons,
and additional surgical capacity in existing and new independent sector
hospitals. The Company continues to support the delivery of the challenging
NHS waiting list reduction targets set by the Government.

 

The Company is expected to deliver growth at the revenue and underlying EBITDA
levels for FY 26, ahead of market expectations(1). Cash at 31 March 2026 was
£11.1m (FY 25: £11.4m) with the Company remaining well-funded to deliver
further organic growth and execute the carefully planned delivery of the
Group's first surgical hub to accelerate growth and improve profitability.

 

(1)Management understands consensus market estimates for revenue and
underlying EBITDA for FY 26 to be £29.4 million and £2.3 million
respectively.

 

Adam Binns, Chief Executive Officer, commented:

"We are delighted to deliver a strong year end trading update ahead of market
expectations for our first full year following our AIM listing and that
construction of our first surgical hub commenced during this period. NHS
national waiting lists remain very high, despite continued NHS efforts and
recent modest reductions, and we are proud that One Health remains
well-positioned to continue to reduce pressure on the NHS by providing free
high-quality care across underserved areas."

 

If you wish to keep up to date on Company news please email:
onehealth@walbrookpr.com (mailto:onehealth@walbrookpr.com)

 

This announcement contains inside information for the purposes of
the UK Market Abuse Regulation

and the Directors of the Company are responsible for the release of this
announcement.

 

For more information, please contact:

 

 One Health Group plc                                                                                                www.onehealth.co.uk/investors (http://www.onehealth.co.uk/investors)

 Derek Bickerstaff, Chairman                                                                                         Via Walbrook PR

 Adam Binns, CEO

 Panmure Liberum (Nominated Adviser and Broker)                                                                      Tel: +44 (0)20 3100 2000

 Emma Earl, Will Goode, Mark Rogers

 Rupert Dearden

 Walbrook PR (Media & Investor Relations)      Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com

                                             (mailto:onehealth@walbrookpr.com)
 Alice Woodings / Paul McManus /

                                             Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 /
 Rachel Broad

                                               +44 (0)7747 515 393

 

About One Health Group plc (www.onehealth.co.uk (http://www.onehealth.co.uk) )

One Health engages 88 NHS Consultants (excluding anaesthetists) who
sub-specialise in the various surgeries offered by the Company, through a
growing network of community-based outreach clinics and surgical operating
locations. One Health continues to deliver strong growth and in the year to
March 2026 provided much needed care to 18,931 new patients, through over
50,000 consultations and over 8,000 surgical procedures. One Health deploys
surgeons and anaesthetists that are mostly employed by the NHS, on a
subcontracted basis. It currently works with over 140 professionals across 14
independent hospitals and 40 outreach clinics. Within these community-based
outreach clinics all consultations and post operative physiotherapy is
delivered where required, reducing patient inconvenience and excess travel.

 

One Health's activities are focused on areas where NHS patient needs are
under-supplied by the local NHS service, population density is relatively high
and the level of private medical insurance or the ability to self-fund is
relatively low. Currently, the Company's activities are focused in Yorkshire,
Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is
derived from 29 ICBs across England as well as contracts with local NHS trusts
to transfer their internal waiting list patients to One Health for quicker
treatment.

One Health's business model has focused to date on four main areas:
orthopaedics, spine, general surgery and gynaecology, with urology introduced
at the end of FY25.

 

Spine and orthopaedics are particularly attractive areas for One Health as the
Directors believe that they benefit from powerful growth drivers in terms of
an ageing demographic, physical inactivity and an increasing proportion of the
population being categorised as obese. Within orthopaedics, the most common
surgeries performed by One Health are knee and hip replacements.

 

Online investor presentation

Click below for the latest online presentation by Derek Bickerstaff, Chairman
and Adam Binns, Chief Executive Officer, which offers insights into the
Company's growth strategy and long-term vision:

https://sparklive.lseg.com/ONEHEALTHGROUP/events/3c988809-19ad-454c-af31-cfe86bfe7da5/one-health-group-half-year-results-announcement
(https://sparklive.lseg.com/ONEHEALTHGROUP/events/3c988809-19ad-454c-af31-cfe86bfe7da5/one-health-group-half-year-results-announcement)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTFLFFSSSISFIR



            Copyright 2019 Regulatory News Service, all rights reserved